Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. The company is headquartered in Hachioji-Shi, Tokyo-To and currently employs 28,838 full-time employees. The firm operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The firm is also engaged in the business activities, including holding companies and financial investments related to each business.
How did OLYMY's recent EPS compare to expectations?
The most recent EPS for Olympus Corporation is $17.76, not beating expectations of $8.95.
How did Olympus Corporation OLYMY's revenue perform in the last quarter?
Olympus Corporation revenue for the last quarter is $17.76
What is the revenue estimate for Olympus Corporation?
According to 8 of Wall street analyst, the revenue estimate of Olympus Corporation range from $285.78B to $255.48B
What's the earning quality score for Olympus Corporation?
Olympus Corporation has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Olympus Corporation report earnings?
Olympus Corporation next earnings report is expected in 2026-11-05
What are Olympus Corporation's expected earnings?
Olympus Corporation expected earnings is $229.74B, according to wall-street analysts.
Did Olympus Corporation beat earnings expectations?
Olympus Corporation recent earnings of $240.4B beat expectations.